Biogen financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2021 2022 2023 2024
Rev. Revenue
$13.44B $14.38B $13.45B $12.27B $11.45B $10.76B $9.70B $6.93B $5.51B $5.04B $4.72B $4.38B $4.10B $3.17B $2.68B $2.42B $2.21B $10.98B $10.17B $9.84B $0.00M
GM % Gross Margin %
86.57% 86.40% 86.50% 86.72% 87.48% 88.48% 87.93% 87.63% 90.11% 90.73% 91.66% 91.27% 90.19% 89.43% 89.77% 84.58% 74.94% 80.79% 77.61% 74.24% 0.00%
OM Operating Margin
34.63% 50.63% 47.31% 47.96% 49.86% 46.59% 40.89% 35.92% 33.34% 35.11% 33.41% 29.59% 30.00% 27.23% 27.98% 15.92% 1.96% 31.24% 29.63% 19.14% 0.00%
EPS Earnings Per Share
$1.57 $2.25 $2.74 $3.66 $4.12 $5.15 $5.90 $6.53 $8.96 $13.83 $17.01 $20.22 $21.81 $26.20 $33.57 $33.70 $19.22 $17.67 $14.72 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0.00% 0.00% 0.00% 0
Sha. Shares
153.88m 180.44m 201.48m 211.48m 217.57m 222.9m 236.16m 236.21m 236.6m 242.92m 238.3m 289.2m 291.75m 293.37m 337.13m 339.41m 333.55m 146.89m 144m 144.9m 145.36m
OCF Operating Cash Flow
$4.23B $7.08B $6.19B $4.55B $4.59B $3.92B $2.94B $2.35B $1.88B $1.73B $1.62B $1.07B $1.56B $1.02B $841.27M $889.50M $727.99M $3.64B $1.38B $1.55B $0.00M
FCF Free Cash Flow
$3.81B $6.56B $5.42B $3.68B $3.91B $3.07B $2.65B $2.10B $1.63B $1.52B $1.45B $909.25M $1.29B $734.64M $642.96M $571.12M $366.98M $3.38B $1.14B $2.05B $0.00M
FCFS Free Cash Flow Per Share
$22.86 $34.25 $25.87 $12.17 $17.67 $14.14 $11.11 $-4.91 $6.83 $6.27 $5.75 $3.16 $4.40 $2.33 $1.90 $1.70 $1.07 $22.43 $7.85 $8.54 $0.00